PYC Therapeutics News and Activities

PYC Therapeutics is a company listed under the stock ticker PYC (ASX).

View the org chart displaying its 9 main executives

Most searched biographies at PYC Therapeutics

• Alan Tribe, Managing Director
• Peter Coleman, Chairman of the Board and Independent Non-Executive...
• Daniel Coletta, Company Secretary

Popular executive movements at PYC Therapeutics

• Kevin Hart, Company Secretary, will retire on Mar. 31, 2026  (posted on March 5 2026).
• Daniel Coletta will join the company as Company Secretary on Mar. 31, 2026  (posted on March 5 2026).
• Andrew Taylor, Chief Financial Officer & Joint Company Secretary, will leave the company on Nov. 18, 2025  (posted on November 13 2025).

Click here to view some more movements at PYC Therapeutics

Create your alert
to follow the executive moves at PYC Therapeutics.

PYC Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by PYC Therapeutics

• Investors & News | PYC Therapeutics

Social media about PYC Therapeutics

• PYC Therapeutics on Wikipedia, Google News & Yahoo Finance
• PYC Therapeutics on LinkedIn, X (Twitter) & YouTube